HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Vistagan-Liquifilm in the treatment of simple glaucoma].

Abstract
Thirty patients (60 eyes) with bilateral open angle glaucoma in whom normalization of the IOP could not be obtained by a conservatory treatment with miotics are presented. In the period of 3 months they were given twice daily a 0.5% solution of Vistagan-Liquifilm, a compound blocking as well the beta 1 as the beta 2 receptors. After 2 weeks 76.7 p.c. of the treated eyes showed a normalization of the intraocular pressure and 23.3 p.c. an improvement. After 3 months the IOP was normalized in 73.3 p.c.; an improvement showed 26.7 p.c. of the eyes. The compound was well tolerated and did not cause any complications from the side of the respiratory or circulatory system.
AuthorsS Szymankiewiczowa
JournalKlinika oczna (Klin Oczna) Vol. 91 Issue 6 Pg. 163-4 (Jun 1989) ISSN: 0023-2157 [Print] Poland
Vernacular TitleVistagan-liquifilm w leczeniu jaskry prostej.
PMID2576678 (Publication Type: Clinical Trial, English Abstract, Journal Article)
Chemical References
  • Adrenergic beta-Antagonists
  • Benzalkonium Compounds
  • Ophthalmic Solutions
  • vistagan-liquifilm
  • Levobunolol
Topics
  • Adrenergic beta-Antagonists (administration & dosage)
  • Adult
  • Benzalkonium Compounds (administration & dosage)
  • Clinical Trials as Topic
  • Female
  • Glaucoma, Open-Angle (drug therapy, physiopathology)
  • Humans
  • Intraocular Pressure (drug effects)
  • Levobunolol (administration & dosage)
  • Male
  • Middle Aged
  • Ophthalmic Solutions

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: